VMP 42534411000001107

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Dolutegravir 5mg / Abacavir 60mg / Lamivudine 30mg dispersible tablets sugar free
BNF code 0503010AZAAAAAA
Virtual Therapeutic Moiety Dolutegravir + Abacavir + Lamivudine
Abbreviated name Dolutegravir 5mg/Abacavir 60mg/Lamivudine 30mg disp tab SF
Basis of preferred name Other
Date of name applicability 2 Apr 2025
Previous name Generic Triumeq 5mg/60mg/30mg dispersible tablets sugar free
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Dolutegravir sodium
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 713464000
Strength value numerator 5.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Lamivudine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Abacavir sulfate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 387005008
Strength value numerator 60.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Dispersible tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Triumeq 5mg/60mg/30mg dispersible tablets (ViiV Healthcare UK Ltd)
Virtual Medicinal Product Packs
Dolutegravir 5mg / Abacavir 60mg / Lamivudine 30mg dispersible tablets sugar free 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.

Feedback